Raw data. by Aaron L. Sayler (19797446)

Subjects:

Mean concentrations of sum cannabinoids, CBD, Cannabichromene, δ8-Tetrahydrocannabinol, δ9-Tetrahydrocannabinol, and other EO constituents (acid asters, ketone, alcohol) obtained f... by Valtcho D. Zheljazkov (627617)

Primer sequences for quantitative RT-PCR. by Li Li (14993)

“…Compared with the Model Group, the red blood cell (RBC) count, hemoglobin (HB) content and hematokrit (HCT) of rats blood routine in the Model+high doses of CBMHL Group (Model+H-CBMHL Group) increased significantly (<i>P</i> < 0.05). Serum erythropoietin (EPO) and glutathione (GSH) levels increased significantly (<i>P</i> < 0.05), while serum creatinine (Cr) levels decreased significantly(<i>P</i> < 0.05). …”

The freeze-drying curve of liposomes. by Li Li (14993)

“…Compared with the Model Group, the red blood cell (RBC) count, hemoglobin (HB) content and hematokrit (HCT) of rats blood routine in the Model+high doses of CBMHL Group (Model+H-CBMHL Group) increased significantly (<i>P</i> < 0.05). Serum erythropoietin (EPO) and glutathione (GSH) levels increased significantly (<i>P</i> < 0.05), while serum creatinine (Cr) levels decreased significantly(<i>P</i> < 0.05). …”

Certificate for laboratory animal. by Li Li (14993)

“…Compared with the Model Group, the red blood cell (RBC) count, hemoglobin (HB) content and hematokrit (HCT) of rats blood routine in the Model+high doses of CBMHL Group (Model+H-CBMHL Group) increased significantly (<i>P</i> < 0.05). Serum erythropoietin (EPO) and glutathione (GSH) levels increased significantly (<i>P</i> < 0.05), while serum creatinine (Cr) levels decreased significantly(<i>P</i> < 0.05). …”

Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

“…This study identified FHND5032, a novel small-molecule miR-124 inducer, as a potent therapeutic candidate for UC. …”

Sociodemographic characteristics of participants at baseline, overall and by age group. by Chelsea S. Lutz (16001569)

Subjects:

Symptoms self-reported and/or documented in the electronic health record during the acute COVID-19 illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Sociodemographic and clinical characteristics associated with PCC at three months post-acute illness among adults enrolled during Omicron predominance. by Chelsea S. Lutz (16001569)

Subjects:

Rarefaction curves of quality reads per sample at (A) phylum and (B) genus level operational taxonomic units (OTUs), in patient and control samples. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Alpha-diversity analysis at genus level including operational taxonomic unit (OTUs), Chao richness and Shannon diversity indices. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Clinical characteristics of patients and controls. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

(A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbial metabolic potentials categorized according to KEGG (A) level 1 and (B) level 2, representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Manifestations of Post-COVID-19 Conditions (PCC) three months post-acute illness, among those with PCC, by age group^a. by Chelsea S. Lutz (16001569)

Subjects:

Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and simple steatosis (SS) groups, and adjusted p-values. by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatotic liver disease (MASLD) groups,... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)